免疫检查点抑制剂心肌炎的诊断和治疗的最新情况
Anthony M Hachem1, Aditya Desai1,2, Noah Beinart1
1University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Current cardiology reports
|April 3, 2025
概括
免疫检查点抑制剂心肌炎的诊断和管理正在发展. 较新的方法包括内肌心活检用于诊断和增加使用类固醇节约性免疫抑制剂,试验调查 abatacept.
科学领域:
- 心脏病学 心脏病学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 免疫检查点抑制剂 (ICI) 是关键的癌症疗法.
- 心肌炎是ICI的罕见但严重的不良影响.
- 早期诊断和适当的治疗对于患者的治疗结果至关重要.
研究的目的:
- 审查当前关于诊断免疫检查点抑制剂心肌炎的文献.
- 更新ICI诱导心肌炎的不断变化的管理策略.
- 介绍专家的经验和对这种情况的方法.
主要方法:
- 关于ICI心肌炎的诊断和管理的综合文献综述.
- 对最近的临床研究和随机对照试验的分析.
- 专家临床经验和治疗算法的综合.
主要成果:
- 现在的诊断方法在某些特定情况下强调内心肌肉活检.
- 识别疾病严重程度的范围,从轻度到 fulminant.
- 治疗趋势包括越来越多地使用类固醇节约剂和新疗法,如 abatacept.
结论:
- 免疫检查点抑制剂心肌炎的诊断和管理正在取得进展.
- 有一系列的临床表现和活检发现存在.
- 进一步的研究,包括RCT,正在指导优化治疗策略.
相关概念视频
Heart Failure Drugs: Inotropic Agents
451
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
451
Imaging Studies for Cardiovascular System I:Echocardiography
274
Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
274
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
334
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
334


